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Abstract
Background: Eastern equine encephalitis virus (EEEV), an arbovirus, is an important human and veterinary pathogen
belonging to one of seven antigenic complexes in the genus Alphavirus, family Togaviridae. EEEV is considered the
most deadly of the mosquito-borne alphaviruses due to the high case fatality rate associated with clinical infections,
reaching up to 75 % in humans and 90 % in horses. In patients that survive acute infection, neurologic sequelae are
often devastating. Although natural infections are acquired by mosquito bite, EEEV is also highly infectious by aerosol.
This fact, along with the relative ease of production and stability of this virus, has led it to being identified as a
potential agent of bioterrorism.
Methods: To characterize the clinical course and outcome of EEEV strain FL93-939 infection, we compared clinical
parameters, cytokine expression, viremia, and viral titers in numerous tissues of mice exposed by various routes.
Twelve-week-old female BALB/c mice were infected by the intranasal, aerosol, or subcutaneous route. Mice were
monitored for clinical signs of disease and euthanized at specified time points (6 hpi through 8 dpi). Blood and
tissues were harvested for cytokine analysis and/or viral titer determination.
Results: Although all groups of animals exhibited similar clinical signs after inoculation, the onset and severity differed.
The majority of those animals exposed by the aerosol route developed severe clinical signs by 4 dpi. Significant
differences were also observed in the viral titers of target tissues, with virus being detected in the brain at 6 hpi in
the aerosol study.
Conclusion: The clinical course and outcome of EEEV infection in mice is dependent on route of exposure. Aerosol
exposure to EEEV results in acute onset of clinical signs, rapid neuroinvasion, and 100 % mortality.
Keywords: Alphavirus, Eastern equine encephalitis virus, Neuroinvasion, Mice
Background
Viruses of the genus Alphavirus, family Togaviridae, are
significant human pathogens maintained by an enzootic
cycle between mosquitoes and vertebrates. They can be
generally divided by geography and pathology into the
Old World alphaviruses such as Chikungunya, Ross River,
and O’nyong-nyong viruses, which are usually associated
with a mild to severe arthralgic disease in humans, and
the New World alphaviruses such as western equine
encephalitis virus (WEEV), Venezuelan equine enceph-
alitis virus (VEEV), and eastern equine encephalitis
virus (EEEV), which cause a mild to severe encephalitis
in both humans and equids. Previously, EEEV was fur-
ther divided into the highly pathogenic North American
antigenic group (NA EEEV) and the three Central and
South American antigenic groups, which only occasion-
ally cause human disease (SA EEEV) [1, 2]. Recent
changes in taxonomy identify NA EEEV strains as EEEV
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and SA EEEV are a new species designated Madariaga
viruses (II-IV) [1]
Because of its high mortality (36-75 %) [3], lack of a li-
censed human vaccine and effective antiviral therapy,
and its potential use as a biological weapon, EEEV is
listed as a category B agent by the National Institute of
Allergy and Infectious Diseases (NIAID). Therefore, re-
search directed towards understanding the pathogenesis
of EEEV, the difference in virulence between EEEV and
Madariaga virus strains, and the development of a safe
and effective vaccine and antiviral treatment for humans
is essential. However, research has been hampered by
the fact that mice develop age-dependent resistance to
peripheral infection. Recently, EEEV, FL 93–939 was
shown to be virulent in adult mice when administered
peripherally; however there is limited information re-
garding the pathogenesis of this strain, with most studies
focusing on the mechanism of decreased type I IFN in-
duction in infected mice [4–6]. Characterizing the clin-
ical course and outcome of EEEV strain FL93-939 in
mice using various routes of infection is an important
first step in understanding the pathogenesis of the NA
EEEV strains, which is paramount when developing a
vaccine and/or therapeutic to prevent the disease.
A comprehensive study was performed to determine
and compare the clinical course of NA EEEV FL93-939
infection of mice following infection by the intranasal
(IN), aerosol (AE), and subcutaneous (SC) routes. The
AE route is the likely route of exposure to an EEEV bio-
weapon and one way by which laboratory workers may
be accidentally exposed. However, many investigators do
not have the equipment necessary to conduct AE studies
and often use IN as a proxy exposure method. Identify-
ing any differences in pathogenesis will be important for
the proper interpretation of future studies utilizing ei-
ther of these routes. The SC route of exposure is meant
to mimic two unintentional exposure scenarios: labora-
tory exposure via contaminated needle puncture and
natural infection from the bite of an infected mosquito,
with the caveat that needle inoculation is not a perfect
substitute for a mosquito bite [7].
Here the clinical course of disease, including clinical
sign onset and duration, as well as complete blood
count, serum analysis, and tissue distribution of virus
over time following infection is presented. A subsequent
manuscript will present tissue pathology associated with
the various routes of exposure.
Results
Weight variance and clinical signs
The post-exposure weight variance and onset of clinical
signs following IN and AE exposure were similar (Fig. 1).
Both groups of mice continued to gain weight up to 2
dpi. However, the IN group began to lose weight by 3
dpi, while the AE group had minimal increases in weight
over the same time period. For both groups, there was
rapid weight loss from 3 dpi to 4 dpi and the IN group
continued to lose weight through the end of the study, 5
dpi. The AE study was terminated on 4 dpi because



























































Intranasal          Aerosol          Subcutaneous          Control
Fig. 1 Change in mean body weight (a) and percent of BALB/c mice that either displayed clinical signs of disease or were moribund (b) after
intranasal, aerosol, or subcutaneous infection with EEEV strain FL93-939. Mice were monitored daily after infection and percent change in weight
was determined from the day of infection (day 0). Note that the aerosol study was terminated at 4 dpi because 90 % of the animals in the 5 dpi
group had moderate to severe signs of clinical disease. (*) Three animals in the subcutaneous study from the 8 dpi group were euthanized prematurely
due to the onset of severe clinical disease
Honnold et al. Virology Journal  (2015) 12:152 Page 2 of 14
euthanized at 5 dpi were showing moderate to severe
signs of clinical disease. In both the IN and AE studies,
mice began displaying clinical signs of disease (ruffled
fur, lethargy, hunched posture) at 3 dpi and both the
percentage of animals affected and the severity of clinical
signs increased from 3 dpi to the study endpoints. More
severe clinical signs of disease included weight loss, de-
hydration, head tilt, circling, head tremors, focal muscle
twitching, lateral recumbency, and rarely seizures.
On the other hand, mice exposed by the SC route ini-
tially lost weight at 1 dpi but gradually gained weight
over the following 5 days. Mice began losing weight after
5 dpi, which coincided with the onset of clinical signs
in most animals. Three of the ten animals from the 8
dpi group were moribund and were euthanized on ei-
ther 6 dpi or 7 dpi. The 7 remaining animals in the 8
dpi group were clinically normal and gaining weight
at 8 dpi. The clinical signs of disease observed in the
SC study were similar to those noted in the IN and
AE studies but occurred in fewer animals and gener-
ally were not noted until 6 dpi. However, one animal
in the 8 dpi group did show clinical signs of disease
starting on 2 dpi. Disease progressed slowly in this
animal until it was euthanized on 7 dpi due to severe
clinical signs of disease.
Temperature and activity
Temperature and activity data were collected from EEEV
infected and uninfected BALB/c mice to evaluate differ-
ences between various routes of infection and age-
matched controls. The average daily temperature range
was 35.2 - 37.8 °C. The mean temperature profile for each
group is shown in Fig. 2a. The diurnal temperature pat-
tern in IN and AE EEEV infected mice began to deviate
from the pattern observed in control mice approximately
3–4 dpi, which coincided with onset of clinical signs. In
SC infected animals, the diurnal temperature pattern was
unchanged until 6–7 dpi, which coincided with the time
at which the highest percentage of animals displayed clin-
ical signs. The fever, detected by telemetry at 3 dpi for the
IN and AE studies and 5 dpi in the SC study (Table 1),
was the first indication that telemetric analysis coincided
with the daily cage-side observations in detecting onset of
disease. However, when comparing infected to uninfected
mice within each study, only the infected animals in
the AE and SC studies showed a significant difference
in the duration and total fever hours relative to unin-
fected controls (p < 0.05), which may be a result of
the small group numbers. In the AE study, 4 of 5 an-
imals had a fever of significant duration; however, in
the IN study only 3 of 5 animals had a fever for 2 or
more consecutive time points. Nevertheless, the p-
value in the IN study was just slightly above 0.05 for
both duration and total fever hours (p = 0.08 for dur-
ation and p = 0.09 for total fever hours).
Distinct diurnal patterns in activity were recorded over
a 24 hr period in all groups, with activity generally peaking
during nocturnal time points and reaching daily lows in
the morning hours (Fig. 2b). When compared to control
mice, mice in both the IN and AE studies deviated from
A B
Fig. 2 Change in average body temperature (a), and activity (b) after intranasal, aerosol, or subcutaneous infection with NA EEEV strain
FL93-939. Body temperatures and activity were recorded for a 20 sec period every 30 min via an intraperitoneal telemetry device before
and after infection with EEEV strain FL93-939. Values represent the average within the cohort (intranasal n = 5; aerosol n = 5; subcutaneous
n = 9; control n = 15). Note that the aerosol study was terminated at 4 dpi because 90 % of the animals in the 5dpi group were showing
moderate to severe signs of clinical disease
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the pattern observed in control mice between 3–5 dpi,
again coinciding with the onset of clinical signs.
CBC analysis
When an adequate volume of blood was collected at
euthanasia, a complete blood count was performed on
individual animals from the AE and SC studies. Group
mean results are shown in Fig. 3. Significant variation
among individuals was observed, which resulted in large
standard deviations in some groups. However, in AE
infected animals, there was a general decrease in the
total number of white blood cells (WBC) (leukopenia)
by 2 dpi, with the group mean value dropping below the
normal (control group) range and remaining low through
the end of the study. This decrease in WBCs was charac-
terized by a decrease in lymphocytes (lymphopenia), while
the number of neutrophils and monocytes (Fig. 3a-d), as
well as the number of eosinophils and basophils (data not
shown), remained within the normal range. Significant dif-
ferences (p < 0.05) were observed in total WBC and num-
ber of lymphocytes between infected and uninfected
animals from 12 hpi through the end of the study
(Table 2). Interestingly, while the mean total number of
neutrophils in infected animals never fell below the nor-
mal range at any time point, there were significant differ-
ences in the total number of neutrophils present in
infected and uninfected animals at every time point. There
were also significant differences in the number of platelets
at 0.25 dpi and 0.5 dpi hpi. A leukopenia was also
observed in SC infected animals; however, this occurred
earlier, at 1 dpi, and when evaluating group means, was
characterized by both a lymphopenia as well as a neutro-
penia. These values remained low through 2 dpi for lym-
phocytes and 3 dpi for neutrophils, after which time all
mean values returned to the normal range for the remain-
der of the study. No significant differences between SC in-
fected and uninfected animals were observed at any of the
time points. The AE and SC group mean values for red
blood cells remained within the normal range for the dur-
ation of the study.
Cytokine analysis
To characterize and compare route-specific induction of
inflammatory and immunomodulatory cytokines and
chemokines, a subset of serum samples were analyzed
from the IN, AE, and SC studies for the presence of 25
soluble proteins (sCD62E, sCD62L, G-CSF, GM-CSF,
IFN-γ, IL-1α, IL-1β, IL-2, I L-3, IL-4, IL-5, IL-6, IL-9, IL-
10, IL-12/IL23p40, IL-13, IL-17A, IL-21, KC/CXCL1,
MCP-1/CCL2, MIG.CXCL9, MIP-1α/CCL3, MIP-1β/
CCL4, RANTES/CCL5, and TNF). There were no sig-
nificant differences in any of the 25 cytokines and che-
mokines tested between aerosol and intranasal infection
at any time point. However, there were several differ-
ences between subcutaneous and intranasal or aerosol
infections (Fig. 4). Subcutaneous infection resulted in an
increase of IFN-γ, MIP-1β, RANTES, and MIG at 1 dpi
compared to aerosol or intranasal infection, followed by
a return to baseline at 2 dpi. These same cyto/chemo-
kines were increased in aerosol and intranasal infection
at 2 dpi relative to subcutaneous infection. Infection by
all three routes generated a late increase in G-CSF levels:
4 dpi following IN or AE infection and 6–7 dpi after SC
infection.
Virus titrations
Viral titers in the serum, bronchoalveolar lavage (BAL),
nasopharyngeal flush (NF), and several tissues were de-
termined by standard plaque assay. Large differences in
viral load were detected in most samples based on the
route of infection. However, substantial variability was
noted between animals in any one group. For this rea-
son, the data shown is for both individual animals as
well as group mean titers.
Table 1 Summary of fever data for IN, AE, and SC studies
Group Onseta ΔTmax, °C Duration, hb Fever hoursc Average elevationd
IN Infected 3.0 1.9 11.3 28.2 1.9
Controls – 1.1 0.6 1.1 1.1
p-value – 0.2972 0.0822 0.0913 0.3166
AE Infected 3.0 2.3 11.6 26.5 1.8
Controls – 0.5 0.4 0.9 0.4
p-value – 0.0405 0.0302 0.0350 0.0670
SC Infected 5.0 1.8 5.9 12.9 1.6
Controls – 0.7 0.2 0.4 0.7
p-value – 0.1000 0.0436 0.0485 0.1144
ΔTmax = the maximum change in temperature
aDefined as the first day with >8 hours of significant temperature elevation (as determined by ARIMA modeling)
bCalculated as the number of hours of significant temperature elevation
cCalculated as the sum of the significant temperature elevations
dCalculated by dividing fever hours by fever duration in hours
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Viremia was first detected in the SC study at 12 hpi,
while viremia was not detected until 1 dpi in either the
IN or AE studies (Fig. 5a). This was likely due to the
route of infection and rapid viral replication at the in-
oculation site. However, viremia remained low in the SC
study and was not detected after 4 dpi. In contrast, while
viremia appeared at 1 dpi in both the IN and AE studies,
it peaked at 2 dpi, was substantially higher than the SC
study, and was present until the study endpoint.
As expected, no virus was detected in the BAL or NF
during the early time points in the SC study (Figs. 5b











































































































































Aerosol          Subcutaneous
Fig. 3 Complete blood counts in mice exposed to EEEV strain FL93-939 either by the aerosol or subcutaneous routes. Numbers shown are the
mean ± standard deviation of total white blood cells (a), lymphocytes (b), neutrophils (c), monocytes (d), platelets (e), and red blood cells (f), at
each time point (n = 10 per time point per route). Normal ranges (black boxes) were determined from control animals (n = 20) combined from
both routes of exposure (white blood cells = 2.4-6.3 x 103/μL, neutrophils = 0.5-1.8 x 103/μL, lymphocytes = 1.2-4.6 x 103/μL, monocytes = 0.1-0.3 x
103/μL, red blood cells = 7.6-8.7 x 106/μL, and platelets = 458.9-914.6 x 103/μL). Note that the aerosol study was terminated at 4 dpi because 90 %
of the animals in the 5dpi group were showing moderate to severe signs of clinical disease
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Table 2 P-values for the pairwise comparisons of mean blood parameters between animals infected by the AE or SC route and
uninfected animals (n = 10)
Days post-exposure (dpi)
Study Blood Parameter 0.25 0.5 1 2 3 4 5 6 7 8
AE WBC # 0.0563 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 – – –
Neutrophil # 0.0366 <0.0001 <0.0001 <0.0001 0.0001 0.0002 0.0210 – – –
Lymphocyte # 0.1292 <0.0001 0.0038 <0.0001 <0.0001 <0.0001 <0.0001 – – –
Monocyte # 1 0.7840 0.2948 1 1 0.2948 1 – – –
Eosinophil # 1 1 1 1 0.7126 1 1 – – –
Basophil # 0.0086 0.9014 0.8748 0.0473 0.1029 0.2591 0.7711 – – –
Hematocrit 0.1232 0.6098 0.7575 0.7030 0.6373 0.7575 0.0297 – – –
Platelet # 0.0016 0.0058 0.2013 0.4579 0.6875 0.8702 0.8702 – – –
SC WBC # 0.5959 1 0.1037 0.3519 1 1 1 1 1 1
Neutrophil # 1 1 0.9472 0.9975 0.7343 1 1 1 1 1
Lymphocyte # 0.0557 1 0.6456 1 1 1 1 1 1 1
Monocyte # 0.2604 0.2320 1 0.3549 0.4931 1 0.8363 1 1 1
Eosinophil # 1 1 1 1 1 1 1 0.1933 1 1
Basophil # 1 1 0.5224 1 1 1 1 1 1 0.9507
Hematocrit 1 0.0886 1 1 1 1 1 1 1 0
Platelet # 1 0.7499 1 0.9118 1 0.4313 0.8769 1 1 0
Intranasal            Aerosol          Subcutaneous
s
Fig. 4 Serum analysis of soluble proteins in mice infected with EEEV strain FL93-939 by the intranasal, aerosol, or subcutaneous route. Infected
mice were euthanized at specified time points. Soluble proteins in the serum were determined using BD Cytometric Bead Array mouse soluble
protein flex sets and analyzed using FCAP Array software. Values represent the group mean at each time point (n = 6), bars represent the standard
deviation. Mean baseline values (0 dpi) were determined from uninfected controls (n = 6)
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at 6 hpi and 12 hpi in the AE study as compared to
the IN study, and virus levels remained higher
throughout the study. Virus was not present in the NF
until 1 dpi in the AE study and 2 dpi in the IN study.
Similar to the titers in the BAL, those in the NF were
higher in AE study throughout all time points, al-
though the overall titers were lower and the differ-
ences less distinct. These observations were likely due
to the difference in delivery method. The collision
nebulizer used for the AE study is designed to gener-
ate small 1 μm particles, many of which are small
enough to be delivered into the terminal bronchioles,
while some particles are likely to remain in direct con-
tact with olfactory nasal epithelium, allowing for at-
tachment, entry, and replication. Virus in the IN study
was delivered in liquid form, 10 μL per nostril, some
may have remained outside the nostril and some may

























































































































Intranasal          Aerosol          Subcutaneous          Control
Fig. 5 Distribution of EEEV FL93-939 in fluids and tissues of BALB/c mice exposed by various routes. Shown are the geometric mean virus titer of
individual animals in the serum (a), bronchoalveolar lavage (BAL) (b), nasopharyngeal flush (NF) (C) and brain (D) (n = 5/time point). Symbols
represent individual animals with values calculated from the geometric mean titer of all dilutions which had at least one visible pfu by
standard plaque assay. The mean for the group is shown in the colored dashed line. The limit of detection of the assay is 5 pfu/ml fluid or
tissue homogenate supernatant
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Virus titers in the tissues followed similar trends. Al-
though the mice in the IN and AE studies received simi-
lar LD50 doses of virus, virus was present in the brain 6
hpi in the AE study, but did not appear until 1 dpi in
the IN study (Fig. 5d). Virus titers in the brain continued
to increase in both groups, with mice of the AE group
consistently having higher titers than mice in the IN
group at all time points, peaking with very high titers at
4 dpi in the AE study and 5 dpi in the IN study. In the
SC study, virus was first detected in one animal in the
brain at 1 dpi, similar to the IN study; however, titers
remained lower in the SC study, as compared to the AE
and IN studies, for all time points, with virus titer peak-
ing later, at 7 dpi. Virus titers in the lung (Fig. 6a) in the
IN and AE studies were similar at 6 hpi, and in both
studies continued to rise to fairly high titers through 2
dpi; however, the titers in the AE study were significantly























































































































Intranasal          Aerosol          Subcutaneous          Control
Fig. 6 Distribution of EEEV FL93-939 in tissues of BALB/c mice exposed by various routes. Shown are the geometric mean virus titer of
individual animals in the lung (a), submandibular salivary gland and lymph node (b), spleen (c), and mesenteric lymph node (d) (n = 5/time
point). Symbols represent individual animals with values calculated from the geometric mean titer of all dilutions which had at least one
visible pfu by standard plaque assay. The mean for the group is shown in the colored dashed line. The limit of detection of the assay is 5
pfu/ml tissue homogenate supernatant.
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was not present in the lung in the SC study until 4 dpi
and titers remained low even at 6–7 dpi. The mandibu-
lar salivary gland and lymph nodes were collected and
analyzed together due to their intimate association
anatomically. The mandibular lymph nodes, also known
as the mandibular and accessory mandibular lymph
node, submandibular lymph nodes, or superficial cer-
vical lymph nodes [8], are a small group of lymph nodes
that drain the structures of the muzzle [9] and were
therefore of interest in the IN and AE studies. As might
be expected, virus was present at low levels in the man-
dibular lymph nodes in both the IN and AE studies at 1
dpi (Fig. 6b) and titers slowly increased throughout the
remaining time points, peaking at 5 dpi and 4 dpi, re-
spectively. In the SC study, virus was not present in the
mandibular lymph nodes until 4 dpi and remained at
relatively low levels through 7 dpi. Virus at this site
could be the result of drainage from the nasal cavity or
seeding from viremia. Virus titers in the spleen (Fig. 6c)
followed similar trends, with virus first appearing in the
spleen at 1 dpi in the AE study and at 2 dpi in the IN
study; titers increased throughout the study and peaked
at 4 dpi and 5 dpi, respectively. In the SC study, virus
appeared at 3 dpi, peaked at 4 dpi and slowly decreased
over the remaining time points. The mesenteric lymph
node, which drains the digestive tract, is a distant lymph
node for all routes of infection, and virus present in this
lymph node may be indicative of distant viral spread by
either blood or lymph. The virus titers in this tissue were
low for all routes of infection and peaked at 3 dpi in the
AE study, 5 dpi in the IN study, and 7 dpi in the SC
study (Fig. 6d). Mean group virus titers of the remaining
tissues (liver, heart, kidneys, adrenal glands, and pan-
creas) evaluated in all three studies are shown in
Additional file 1: Figure S1. No virus was present in any
of these tissues until 1 dpi and virus titers remained very
low throughout most time points. The slight increase in
titer in the heart and kidneys could be due to poor per-
fusion of these vascular organs with PBS prior to tissue
collection. Overall, the differences in virus titer in the
various tissues are likely due to the variation in delivery
method and virus dose. In the IN and AE studies, in
which mice received approximately 100LD50, virus was
present early on and at high titer in the serum, BAL,
brain, and lung. The viral titer in the remaining tissues
was lower and peaked later in the time course. While in
the SC study, in which mice received approximately
30LD50, the viral titer in tissues was generally lower and
peaked later in the course of disease.
To more accurately trace the path of the virus in the
SC study, mice were inoculated in the left rear footpad
and subsequent samples were collected from the left and
right footpad, foot, gastrocnemius muscle, and popliteal
lymph node for viral titer. As expected, the viral titer
was high in the left footpad and left foot early in infec-
tion (6 hpi) and remained high throughout all time
points, whereas virus appeared at low levels in the right
footpad and right foot after 12 hpi and 2 dpi and peaked
at 4 dpi and 3 dpi respectively (Fig. 7). There was signifi-
cant viral replication at the site of inoculation (left foot-
pad and foot) as the mice received approximately 1000
pfu/footpad and the titers reached 106 pfu/gm by 1 dpi.
Virus titers were determined for the left and right
gastrocnemius muscle (calf muscle), a large muscle
group in the lower leg, as it has been previously reported
that EEEV replicates in skeletal muscle [10]. The mean
viral titer of left gastrocnemius muscle remained low
throughout the study and virus did not appear in the
right gastrocnemius muscle until 5 dpi (Fig. 8). Virus ti-
ters were also determined for the left and right popliteal
lymph nodes, the draining lymph nodes of the inocula-
tion site. The mean virus titer of the left popliteal lymph
node rose rapidly post-inoculation and remained at high
levels until 6 dpi. While virus was detected in the right
popliteal lymph node 1 dpi, viral titers were more spor-
adic and generally remained low throughout the study.
Discussion
To better understand the pathogenesis of EEEV strain
FL93-939 in mice, several studies were conducted to
evaluate the differences between 3 routes of infection:
intranasal, aerosol, and subcutaneous. Although the in-
tranasal and aerosol routes were similar, there were im-
portant differences noted. While animals in both groups
lost weight between 3–4 dpi, those animals in the AE
study displayed clinical signs of disease at 3 dpi com-
pared to 4 dpi in the IN study. The clinical signs were so
severe in the majority of animals in the AE study at 4
dpi that the study was terminated early. Clinical signs of
disease did not appear until 5 dpi in the SC study. Inter-
estingly though, the absolute dose given per mouse was
similar between the IN and SC routes, 1300 pfu and
1000 pfu respectively, yet the outcome was drastically
different with regard to clinical disease onset and viral
tissue distribution and titers. This is likely due to differ-
ences in inoculation site, the resultant immune response,
and the relative lethal dose given; 100LD50 in the IN
study compared to 30LD50 in the SQ study. The clinical
signs noted in the SC study were similar yet less severe
than previously reported [10]; however, mice in the
Vogel et al. study had severe clinical signs by 4 dpi. The
difference in onset of clinical signs and severity noted in
the Vogel study may be attributed to the virus strain
(FL91–4679), higher inoculum (105 pfu), the mouse
strain (C57/BL6), or the age of the mice (5-weeks) used
in that study, or most likely a combination of these fac-
tors. The clinical findings in our SC study more closely
paralleled those noted recently by Gardner et al. [11] in
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which they did not observe signs of disease until 6 dpi
following a subcutaneous exposure and weight loss was
minimal over the course of the study.
Telemetry was used previously to study non-human
primates infected with EEEV by the aerosol route [12].
However, telemetry had not been used previously to
study EEEV infection in mice, or to compare routes of
infection. As in the non-human primate study, telemetry
proved to be a useful tool in determining onset of clin-
ical disease in mice. Fever was detected at 3 dpi in both
the IN and AE studies, which coincided with the onset
of mild signs (ruffled fur). Additionally, obvious changes
in diurnal patterns in both temperature and activity co-
incided with the onset of more severe clinical signs of
disease. This study highlighted the importance of moni-
toring such parameters and revealed that the clinical
signs in mice, similar to those seen in humans, included
fever prior to or at the onset of more obvious clinical
signs of disease, such as ruffled fur and lethargy.
A complete blood count was performed on animals
from the AE and SC studies; however, the results were
not specific or predictive of outcome. Most animals had
a leukopenia characterized by a lymphopenia at 2–3 dpi,
which can be indicative of a viral infection. These results
were similar to those reported by Adams et al. [13] in
which marmosets infected with EEEV had a leukopenia
1 dpi, but a concomitant decrease in neutrophils, lym-




































Fig. 7 Geometric mean virus titer in the left and right footpad and foot of individual BALB/c mice infected SC with EEEV strain FL93-939 in the
left rear footpad (n = 5). Viral titers of tissue homogenate supernatants were determined by standard plaque assay. Symbols represent individual
animals with values calculated from the geometric mean titer of all dilutions which had at least one visible pfu. The mean for the group is shown




































Fig. 8 Geometric mean virus titer in the left and right gastrocnemius muscle and popliteal lymph node of individual BALB/c mice infected SC
with EEEV strain FL93-939 in the left rear footpad (n = 5). Viral titers of tissue homogenate supernatants were determined by standard plaque
assay. Symbols represent individual animals with values calculated from the geometric mean titer of all dilutions which had at least one visible
pfu. The mean for the group is shown in the colored dashed line. The limit of detection of the assay is 5 pfu/ml tissue homogenate supernatant
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profile rapidly changed to a leukocytosis, characterized
by a neutrophilia, lymphocytosis and a monocytosis by
3–4 dpi. While there was a rise in leukocytes in our SC
study after 3 dpi, the number of leukocytes remained
within the normal range for the study duration. It is dif-
ficult to compare CBC results in research models to that
observed in human cases, since the infectious dose and
time from inoculation to presentation in humans is typ-
ically not known.
Cytokine analysis in EEEV infected research models
has not been reported. While there were several pro-
inflammatory cytokines and chemokines that were
elevated to statistically significant levels relative to
saline-treated control animals, most of the elevated
cyto/chemokine levels were only slightly increased
from baseline. However, temporal comparison of cyto-
kine levels between various routes of infection re-
vealed some interesting results. That no significant
differences were observed among any of the 25 cyto-
kines and chemokines tested between aerosol and
intranasal infection at any time point suggests these
routes of infection induced very similar immune re-
sponses. However, several differences were noted between
subcutaneous and intranasal or aerosol infections. IFN-γ,
MIP-1β (a chemoattractant for macrophages and NK
cells), RANTES (a chemokine for T-cells), and MIG (a
T-cell attractant and activator) were increased one day
following subcutaneous infection relative to aerosol or
intranasal infection, followed by a return to baseline
one day later when the same cyto/chemokines become
increased in aerosol or intranasal infection. sCD62E, a
soluble analogue of the E-selectin cell adhesion mol-
ecule, may also have been increased in both IN and
AE infected animals early in infection. However, the
relatively high level observed in AE-infected day 0
controls prevents a conclusive association. Overall,
these data suggest a mild induction of certain pro-
inflammatory cytokines and chemokines after infec-
tion. It is possible that the earlier spike in IFN-γ, MIP-
1β, RANTES, and MIG levels after subcutaneous
infection contributed to the decreased virulence seen
in these mice compared to intranasal or aerosol infec-
tion. It is noteworthy that this study focused on serum
cytokine and chemokine levels, which may reflect pro-
teins produced by a number of sources, including
circulating immune cells and various target tissues.
Future studies should focus on determining tissue
cytokine levels to further elucidate their source and
potential role in infection and disease control or
exacerbation.
In these studies, virus titration of tissue homogenates
was used to characterize the temporal progression of
EEEV FL93-939 from the site of exposure/inoculation to
the CNS of infected mice. In IN infected animals, virus
was first detected in the blood and the brain homogen-
ate at 1 dpi. By 2 dpi, viremia peaked and the virus titer
in the brain rapidly increased. These data could be sug-
gestive of a vascular route of neuroinvasion or invasion
of the CNS via the olfactory route as observed in guinea
pigs exposed to aerosolized EEEV [14]. However, further
studies using IHC strongly indicate EEEV neuroinvasion
following IN exposure follows the olfactory route [15].
The results for the AE study were very similar to the
results of the IN study, with the important exception
that virus was detected in the brain by titer at only 6 hpi
following aerosol exposure. The aerosol delivery method
likely allowed more virus contact with olfactory neurons,
thus facilitating the earlier viral invasion of the olfactory
bulb and subsequent transport to the olfactory tract and
beyond [15]. These results support the clinical findings
of more rapid and severe disease onset in this study.
The results of the SC study were less clear. Despite
convincing evidence of virus replication near the site of
inoculation and viremia in 30-40 % of animals at the
early time points, viral infection of the brain was not
consistently observed. While virus was first detected in
the brain by plaque assay at 1 dpi (1 of 5 animals, 20 %),
virus was only detected in the brain of 10 of 60 (17 %) of
animals from 3–8 dpi. This may be due to variation in
LD50 dose, immune response, or route of neuroinvasion.
In humans, the incubation period following natural
EEEV infection is short, usually 4–10 days. Systemic in-
fection is often characterized by abrupt onset of chills
and fever followed by malaise, arthralgia, and myalgia.
Typically these are difficult parameters to measure in
animals; however, telemetry allowed for monitoring of
temperature and activity and fever and decreased activity
(lethargy or malaise) were noted in many infected ani-
mals. Clinical signs of encephalitis in humans include
abrupt onset of severe fever, intense headache, irritabil-
ity, restlessness, drowsiness, anorexia, nausea, vomiting,
diarrhea, cyanosis, convulsions, and coma. Again, while
most of these clinical signs cannot be evaluated in mice,
marked lethargy and tremors were noted in some in-
fected animals. In humans, death usually occurs within
2–14 days after the onset of clinical signs [16]. In these
studies, mice generally were moribund or succumbed to
infection within 2–4 days following the onset of clinical
signs.
Conclusion
Together with the follow on report describing the histo-
pathology [15], this study completes a comprehensive
characterization of the infection of BALB/c mice with
EEEV strain FL93-939 by the aerosol, intranasal, and
subcutaneous routes of exposure. These studies confirm
that clinical course, pathogenesis, and outcome of infec-
tion with EEEV are dependent on route of exposure in
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mice. Understanding the differences in disease course
commenced via different exposure routes is essential for




Specific pathogen free 8–10 week-old female BALB/c mice
(NCI, Frederick, MD) were housed in cages equipped with
microisolators and were provided food and water ad
libitum throughout the study. The room temperature was
maintained at 23 ± 1 °C and periods of light and dark were
on a 12 h cycle. Mice were acclimated for 1 week after
which 10 animals in each study were surgically implanted
with intraperitoneal telemetry devices (TA-F20, Data
Sciences International, St. Paul, MN) to monitor body
temperature and activity. Animals received 1 week post-
operative recovery, thus weighed approximately 20 gm, and
were 10–13 weeks old at the time of exposure. For the por-
tions of the study involving live EEEV, mice were housed in
a biosafety level 3 (BSL-3) facility. Human end points were
used during all mouse studies. Research was conducted
under an IACUC approved protocol in compliance with
the Animal Welfare Act, Public Health Service Policy, and
other Federal statutes and regulations relating to animals
and experiments involving animals. The facility where the
research was conducted is accredited by the Association for
the Assessment and Accreditation of Laboratory Animal
Care International and adheres to principles stated in the
Guide for the Care and Use of Laboratory Animals,
National Research Council, 2011.
Virus
EEEV strain FL93-939 was obtained from Dr. Scott
Weaver, UTMB, Galveston, TX. A sucrose-purified work-
ing stock was prepared from seed stock (P1) through an
additional passage (P2) in Vero cells. Virus titer was deter-
mined by standard plaque assay on Vero cell monolayers.
Virus was aliquoted and frozen at −70 to −80 °C prior to
use. Challenge virus was diluted in either Eagle’s mini-
mum essential medium (EMEM) (Cellgro, Mediatech,
Inc., Manassas, VA) or sterilized phosphate buffered saline
(PBS) (GIBCO Invitrogen Corp., Grand Island, NY).
Experimental design
Groups of 10 mice were exposed to approximately
100LD50 of EEEV strain FL93-939 by either the intrana-
sal, aerosol or subcutaneous route. For the intranasal
route of exposure, virus dose was prepared in a 20 μL
volume in sterilized PBS. Control mice received only
sterilized PBS. Mice were briefly anesthetized with iso-
flurane using the IMPAC6 (VetEquip, Inc., Pleasanton,
CA) and given 10 μL of challenge virus per nostril. For
the aerosol route of exposure, virus dose was prepared
in a 10 ml volume in EMEM. Control mice were ex-
posed to diluent only. Aerosol exposures were con-
ducted in a whole-body bioaerosol exposure system. A
Collison nebulizer (BGI, Inc., Waltham, MA) was used to
generate small (1 μm mass median aerodynamic diameter)
diameter particles for each acute 10 min exposure. Briefly,
mice were placed in wire cages, which were then placed
into a chamber where they were exposed to aerosolized
virus for 10 min. ‘Presented’ dose was estimated by calcu-
lating the respiratory minute volume (Vm) using Guyton’s
formula [17], expressed as Vm = 2.10 x Wb
0.75 where Wb =
body weight (gm) based on the average group weights the
day of exposure. The presented dose was then calculated
by multiplying the estimated total volume (Vt) of experi-
mental atmosphere inhaled by each animal (Vt = Vm x
length of exposure) by the empirically determined expos-
ure concentration (Ce) (‘presented dose’ =Ce x Vt). Expos-
ure concentration, expressed in plaque-forming units
(PFU)/L, was determined by isokinetic sampling of the
chamber with an all-glass impinger (AGI) (Ace Glass,
Vineland, NJ). Samples were titrated by standard plaque
assay on Vero cell monolayers [14]. For the subcutaneous
route of exposure, virus dose was prepared in a 10 μL vol-
ume in EMEM. Mice were inoculated in the left foot pad
in order to track viral replication in the surrounding tissue
and draining lymph node (popliteal lymph node). Control
mice received diluent only. Challenge virus preparations
were back-titrated by standard plaque assay using Vero
cells. Mice from the intranasal and aerosol studies were
euthanized at pre-determined time points: 6, 12, 24, 48,
72, 96, and 120 hours post-infection (hpi). In addition to
the previous listed time points, mice in the subcutaneous
study were also euthanized at 144, 168, and 192 hpi. At
the time of euthanasia, mice were anesthetized with
mouse K-A-X (50 mg ketamine (Fort Dodge Animal
Health, Fort Dodge, IA), 0.5 mg acepromazine (Boehrin-
ger Ingelheim, Ridgefield, CT), and 5.5 mg xylazine (Lloyd
Laboratories, Walnut, CA)) given intraperitoneally at a
dose of 0.2 ml per 20 gm. Mice were euthanized by exsan-
guination via cardiac puncture and whole blood samples
were collected for CBC analysis, while serum samples
were collected for viral titer and cytokine analysis. Five
mice from each time point were perfused with PBS and
tissues were individually collected and frozen for viral titer
analysis.
Acquisition and analysis of telemetry data
All telemetry data was collected using the DSI Data-
Quest ARTM™ software. The system was programmed
to sample body temperature and physical activity for a
20 sec period every 30 min. Baseline data was collected
for 2 days. Data collection continued until euthanasia or
the end of the study. Pre-exposure temperature data was
used to develop a baseline period to fit an autoregressive
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integrated moving average (ARIMA) model. Forecasted
values for the post-exposure period were based on the
baseline extrapolated forward in time using SAS ETS
(v. 9.2). Residual changes were determined by sub-
tracting the predicted value from the actual value re-
corded for each time point. For temperature, residual
changes greater than two standard deviations were
used to compute fever duration (number of hours of
significant temperature elevation), fever hours (sum of
the significant temperature elevations), and average
fever elevation (fever hours divided by fever duration
in hours). Only time periods consisting of two or more
consecutive time points of elevated temperature were
used in the analysis.
CBC analysis
A complete blood count (CBC) was determined on whole
blood samples collected at the time of euthanasia. Samples
were run on an Abbott CELL-DYN 3700 with veterinary
package (Abbott Laboratories, Abbott Park, IL) on the
same day as collection. This instrument produces a differ-
ential white blood cell count based on size, internal granu-
larity, and nuclear content using optical and impedance
technology. T-tests with stepdown Bonferroni adjustment
were used to compare mean levels of blood parameters
between infected groups and uninfected control groups at
various time points.
Cytokine analysis
Cytokines/chemokines were measured on selected serum
samples using BD™ Cytometric Bead Array mouse soluble
protein flex sets (BD Biosciences, San Jose, CA) read on a
BD FACSCanto II flow cytometer as per manufacturer’s
instructions. Twenty-five soluble proteins were measured
(sCD62E, sCD62L, G-CSF, GM-CSF, IFN-γ, IL-1α, IL-1β,
IL-2, I L-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12/IL23p40,
IL-13, IL-17A, IL-21, KC/CXCL1, MCP-1/CCL2, MIG.
CXCL9, MIP-1α/CCL3, MIP-1β/CCL4, RANTES/CCL5,
and TNF) and results were analyzed using FCAP Array
software (BD Biosciences).
Mucosal secretions
A bronchoalveolar lavage (BAL) and nasopharyngeal flush
(NF) were performed using 0.5 ml of sterile PBS for each.
Briefly, under deep anesthesia, the trachea was exposed
and an 18G needle was inserted toward the lower or
upper respiratory tract, respectively. PBS was flushed into
the lungs and aspirated for BAL or through the nares and/
or oropharynx for nasopharyngeal flushes. Mice were then
euthanized by exsanguination via cardiac puncture.
Virus titrations
For determination of EEEV titers, tissue samples were
homogenized using a mini-bead beater and 1–2 stainless
steel beads (3.2 mm diameter) (BioSpec Products, Inc.,
Bartlesville, OK) and 500 μL of complete medium. Ho-
mogenized samples were centrifuged for 10 min at
10,000 rpm in a table-top centrifuge and supernatants
were collected and stored at −70 to −80 °C until virus
titration. Titration of virus was performed by standard
plaque assay on Vero cell monolayers. Briefly, super-
natant from homogenized tissues, serum, BAL, nasal
flush, or AGI samples were serially diluted in EMEM (
Cellgro, Mediatech, Inc.) containing 5 % fetal bovine
serum (FBS) (GIBCO Invitrogen Corp.), 1 % penicillin
(20,000 IU/ml)-streptomycin sulfate (20,000 μg/ml), 1 %
non-essential amino acids (NEAA) (Sigma Aldrich
Company, Inc., St. Louis, MO), 1 % 200 mM L-glutam-
ine (Thermo Scientific, Logan, UT), and 0.1 % gentami-
cin solution (Sigma Aldrich Company, Inc.). Diluted
samples were then added in duplicate to 6-well plates
containing confluent monolayer of Vero cells (African
green monkey kidney cells) which were incubated at
37 °C for 1 hour, with rocking every 15 min. Following
the incubation period, a 0.5 % agarose overlay in 2x
EBME solution (GIBCO, Life Technologies) with
HEPES and 10 % FBS, 1 % L-glutamine, 1 % NEAA,
1 % penicillin-streptomycin sulfate, and 0.1 % gentami-
cin was added, and plated were incubated at 37 °C at
5 % CO2 for 24 hr. Thereafter, a second agarose overlay
in 2x EBME containing supplements and 5 % neutral
red was added. The plates were again incubated at 37 °C
at 5 % CO2 for 24 hr. Defined plaques (neutral red exclu-
sion areas) were then counted. The limit of detection for
this assay was 5 pfu/ml.
Additional file
Additional file 1: Figure S1. Geometric mean viral titer in the liver,
heart, kidney, adrenal gland, and pancreas of the groups from BALB/c
mice infected with NA EEEV strain FL93-939 (n = 5). Viral titers of tissue
homogenate supernatants were determined by standard plaque assay.
The limit of detection of the assay is 5 pfu/ml tissue homogenate super-
natant. (PPTX 64 kb)
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